首页> 外国专利> 0.1 - 20 weight containing molybdenum inside skin external use medicine null crystallizing for ultraviolet ray defense,

0.1 - 20 weight containing molybdenum inside skin external use medicine null crystallizing for ultraviolet ray defense,

机译:皮肤内含0.1-20重量%的钼外用药物用于防止紫外线结晶,

摘要

PROBLEM TO BE SOLVED: To obtain scaly powder having high protecting ability against not only UVB but also UVA and to obtain an external preparation for skin capable of effectively preventing photoaging and damage of skin resulting especially from UVA. ;SOLUTION: Scaly powder is coated with titanium oxide containing tungsten or molybdenum in the interior of crystal. One or more are selected from these coated scaly powders are added to an external preparation for skin. The coating treatment of the scaly powder can be carried out by a deposition method or physical and chemical mixed grinding method. The content of tungsten or molybdenum in the titanium oxide is 0.1-20 wt.%. The application amount of the titanium oxide containing tungsten or molybdenum is preferably about 1.0-60.0 wt.%.;COPYRIGHT: (C)1999,JPO
机译:解决的问题:获得不仅对UVB而且对UVA具有高保护能力的鳞片状粉末,并且获得能够有效防止尤其是由UVA引起的光老化和皮肤损伤的皮肤外用制剂。 ;解决方案:鳞状粉末在晶体内部涂有含钨或钼的二氧化钛。从这些涂覆的鳞状粉末中选择一种或多种,​​并添加到皮肤外用剂中。鳞片状粉末的包覆处理可以通过蒸镀法或物理化学混合研磨法进行。氧化钛中钨或钼的含量为0.1-20重量%。含钨或钼的二氧化钛的施加量优选为约1.0-60.0重量%。;版权:(C)1999,JPO

著录项

  • 公开/公告号JP4090093B2

    专利类型

  • 公开/公告日2008-05-28

    原文格式PDF

  • 申请/专利权人 株式会社ノエビア;

    申请/专利号JP19970238987

  • 发明设计人 小林 龍三;

    申请日1997-08-19

  • 分类号A61K8/19;A61K8/29;A61Q1/02;A61Q1/12;A61Q17/04;A61Q19/00;C01G39/00;C01G41/00;C01G23/04;

  • 国家 JP

  • 入库时间 2022-08-21 20:18:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号